Journal of the American Society of Nephrology
2006 JASN IMPACT FACTOR 7.371 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


J Am Soc Nephrol 19: 877-883, 2008
© 2008 American Society of Nephrology
doi: 10.1681/ASN.2007050629

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Korgaonkar, S. N.
Right arrow Articles by He, J. C.
PubMed
Right arrow Articles by Korgaonkar, S. N.
Right arrow Articles by He, J. C.

BRIEF COMMUNICATIONS

HIV-1 Upregulates VEGF in Podocytes

Sonal Navin Korgaonkar*, Xiaobei Feng{dagger}, Michael D. Ross*, Ting-chi Lu*,{ddagger}, Vivette D'Agati§, Ravi Iyengar||, Paul E. Klotman* and John Cijiang He*,{ddagger}

Departments of * Medicine and || Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, {ddagger} James J Peters VA Medical Center, Bronx, § Department of Pathology, Columbia University, New York, New York; and {dagger} Department of Nephrology, Ruijin Hospital, Shanghai, China

Correspondence: Dr. John Cijiang He, 1 Gustave Levy Place, New York, NY 10029. Phone: 212-241-4060; Fax: 212-987-0389; E-mail: cijiang.he{at}mssm.edu

Received for publication May 31, 2007. Accepted for publication February 27, 2008.

HIV-associated nephropathy (HIVAN) is characterized by collapsing FSGS. Because transgenic mice with podocyte-specific overexpression of the vascular endothelial growth factor 164 (VEGF164) isoform also develop collapsing FSGS, we sought to determine whether VEGF plays a role in HIVAN. Compared with controls, immunohistochemistry revealed that kidneys from HIV-1–transgenic mice (Tg26) and from patients with HIVAN had greater expression of both VEGF and its transcriptional regulator, hypoxia-inducible factor 2{alpha} (HIF-2{alpha}). Similarly, mRNA and protein levels of VEGF and HIF-2{alpha} were increased in HIV-infected podocytes in vitro, and this transcriptional upregulation was found to be stimulated by the HIV viral protein Nef in a Src kinase–and Stat3-dependent manner. HIV-1 also upregulated VEGFR2 and its co-receptor neuropilin-1 and suppressed the expression of semaphorin 3a in the podocyte. Exogenous VEGF stimulated proliferation and de-differentiation of podocytes, which are features of collapsing FSGS, and VEGFR2 neutralizing antibodies reversed these features in podocytes infected with HIV-1 or isolated from Tg26 mice. In conclusion, HIV-1 induces VEGF and VEGFR2 expression in podocytes, and this may be a critical step in the pathogenesis of HIVAN.







HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP